These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6876143)

  • 1. Humoral immunity in type 1 diabetes mellitus: a prospective study.
    Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
    J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes in newly diagnosed insulin-dependent (type I) diabetics.
    Irvine WJ; Di Mario U; Guy K; Feek CM; Gray RS; Duncan LJ
    J Clin Lab Immunol; 1978 Nov; 1(3):183-6. PubMed ID: 387959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in Diabetes mellitus.
    Irvine WJ; Sawers JS; Feek CM; Prescott RJ; Duncan LJ
    J Clin Lab Immunol; 1979 Apr; 2(1):23-6. PubMed ID: 95802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in diabetics with severe microangiopathy: evaluation by two different methods.
    Andreani D; Di Mario U; Galfo C; Ventriglia L; Iavicoli M
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):239-44. PubMed ID: 7036632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes and diabetic microangiopathy.
    Irvine WJ; Di Mario U; Guy K; Iavicoli M; Pozzilli P; Lumbroso B; Andreani D
    J Clin Lab Immunol; 1978 Nov; 1(3):187-91. PubMed ID: 756468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New evidence of circulating immune complexes in Crohn's disease using two sensitive methods.
    Pallone F; Montano S; Ricci R; Iavicoli M; Di Mario U
    J Clin Lab Immunol; 1981 Jan; 5(1):23-5. PubMed ID: 7218324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in old people and in diabetics: correlation with autoantibodies.
    Delespesse G; Gausset P; Sarfati M; Dubi-Rucquoy M; Debisschop MJ; van Haelst L
    Clin Exp Immunol; 1980 Apr; 40(1):96-102. PubMed ID: 6993080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in patients with diabetes mellitus.
    Abrass CK; Heber D; Lieberman J
    Clin Exp Immunol; 1983 Apr; 52(1):164-72. PubMed ID: 6305541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatment.
    Di Mario U; Irvine WJ; Guy K; Borsey DQ; Iavicoli M; Ventriglia L
    J Clin Lab Immunol; 1983 May; 11(1):17-20. PubMed ID: 6348294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of immune complexes in disseminated neuroblastoma with serum antibody to bovine serum albumin.
    Beck DA; Rossen RD; Cangir A; DuBois DB
    Cancer Res; 1983 Feb; 43(2):879-85. PubMed ID: 6336661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Decrease in the serum level of the C3 complement component in noninsulin dependent diabetes of recent onset].
    Vialettes B; Lassmann V; Vague P
    Diabete Metab; 1983 Mar; 9(1):66-8. PubMed ID: 6602072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and immunity.
    Mincu I; Cheţa D
    Med Interne; 1983; 21(4):257-66. PubMed ID: 6361973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An islet cell antibody negative form of insulin-dependent diabetes mellitus (IDD) associated with HLA antigens A9 and Bw16.
    Mustonen A; Ilonen J; Akerblom HK; Tiilikainen A
    Clin Exp Immunol; 1982 Apr; 48(1):213-7. PubMed ID: 7044630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.
    Irvine WJ; McCallum CJ; Gray RS; Duncan LJ
    Lancet; 1977 May; 1(8020):1025-7. PubMed ID: 67485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection of circulating immune complexes in normal subjects using four different methods.
    Di Mario U; Guy K; Irvine WJ
    J Clin Lab Immunol; 1981 Mar; 5(2):95-9. PubMed ID: 6971334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral antibacterial immunity in first degree relatives of insulin-dependent diabetics.
    Schernthaner G; Ludwig H; Mayr WR; Eibl M
    Diabete Metab; 1978 Sep; 4(3):163-7. PubMed ID: 710677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.